Ch. 4. Antigen Recognition in the Adaptive Immune System. Flashcards
Immune repertoire
The entire collection of distinct lymphocyte clones.
Complementarity-determining region (CDR)
Short segments of Ig and TCR proteins that contain most of the sequence differences between antibodies or TCRs expressed by different clones of B cells and T cells that make contact with antigen; also called hypervariable regions.
Three CDRs are present in the variable domain of each antigen receptor polypeptide chain, and six CDRs are present in an intact Ig or TCR molecule.
These hypervariable segments assume loop struction that together form a surface complementary to the three-dimensional structure of bound antigen.
B cell receptor (BCR)
The cell surface antigen receptor on B lymphocytes, which is a membrane-bound immunoglobulin molecule.
B cell receptor (BCR) complex
A multiprotein complex expressed on the surface of B lymphocytes that recognizes antigen and transduces activating signals into the cell.
The BCR complex includes membrane Ig, which is responsible for binding antigen, and Ig(alpha) and Ig(beta) proteins, which initiate signaling events.
T cell receptor (TCR)
The clonally distributed antigen receptor on T lymphocytes. The most common form of TCR is composed of a heterodimer of two disulfide-linked transmembrane polypeptide chains, designated alpha and beta, each containing one N-terminal Ig-like variable (V) domain, one Ig-like constant (C) domain, a hydrophobic transmembrane region, and a short cytoplasmic region.
The (alpha)(beta) TCR is expressed on CD4+ and CD8+ T cells and recognizes complexes of foreign peptides bound to self MHC molecules on the surface of APCs. (Another less common type of TCR, composed of gamma and delta chains, is found on a small subset of T cells and recognizes different forms of antigen).
T cell receptor (TCR) complex
foo
Immunoglobulin (Ig)
Synonymous with antibody.
Antibody
A type of glycoprotein molecule, also called immunoglobulin (Ig), produced by B lymphocytes that binds antigens, often with a high degree of specificity and affinity.
The basic structural unit of an antibody is composed of two identical heavy chains and two identical light chains. The N-terminal variable regions of the heavy and light chains from the antigen-binding sites, whereas the C-terminal constant regions of the heavy chains functionally interact with other molecules in the immune system.
Every individual has millions of different antibodies, each with a unique antigen-binding site. Secreted antibodies perform various effector functions, including neutralizing antigens, activating complement, and promoting leukocyte-dependent destruction of microbes.
Fab (fragment, antigen-binding) region
A part of an antibody, first produced by proteolysis of IgG, that includes one complete light chain paired with one heavy chain fragment containing the variable domain and only the first constant domain.
Fab fragments, which an be generated from all antibodies, retain the ability to monovalently bind an antigen but cannot interact with IgG Fc receptors on cells or with complement.
Therefore Fab preparations are used in research and therapeutic applications when antigen binding is desired without activation of effector functions. (The Fab’ fragment retains the hinge region of the heavy chain.)
Fc (fragment, crystalline) region
A region of an antibody molecule that can isolated by proteolysis of IgG that contains only the disulfide-linked carboxyl-terminal regions of the two heavy chains.
The Fc region of Ig molecules mediates effector functions by binding to cell surface receptors or the C1q complement protein. (Fc fragments are so named because they tend to crystallize out of solution.)
Hinge region
The region of Ig heavy chains between the first two constant domains that can assume multiple conformations, thereby imparting flexibility in the orientation of the two antigen-binding sites.
Because of the hinge region, an antibody molecule can simultaneously bind two epitopes that are separated by some distance from one another.
Constant (C) region
The portion of Ig or TCR polypeptide chains that does not vary in sequence among different clones and is not involved in antigen binding.
What are the five types of Ig heavy chains?
Mu, delta, gamma, epsilon, and alpha.
Isotype (class)
One of five types of antibodies, determined by which of five different forms of heavy chain is present.
Antibody isotypes include IgM, IgD, IgG, IgA, and IgE, and each isotype performs a different set of effector functoins.
Additional variations characterize distince subtypes of IgG and IgA.
Heavy-chain isotype (class) switching
The process by which a B lymphocyte changes the isotype, or class, of the antibodies that it produces, from IgM to IgG, IgE, or IgA, without changing the antigen specificity of the antibody.
Heavy-chain isotype switching is stimulated by cytokines and CD40 ligand expressed by helpher T cells and involves recombination of B cell VDJ segments with downstream heavy-chain gene segments.
Epitope (determinant)
The specific part of a macromolecular antigen to which an antibody or T cell receptor binds. In the case of a protein antigen recognized by a T cell, an epitope is the peptide portion that binds to an MHC molecule fo recognition by the TCR.
Can be a linear or conformational epitope.
Affinity
The strength of the binding between a single binding site of a molecule (e.g., an antibody) and a ligand (e.g., an antigen).
The affinity of of a molecule X for a ligand Y is represented by the dissociation constant (Kd), which is the concentration of Y that is required to occupy the combining sites of half the X molecules present in a solution.
A smaller Kd indicates a stronger or higher affinity interaction, and a lower concentration of ligand is needed to occupy the sites.
Affinity maturation
The process that leads to increased affinity of antibodies for a particular antigen as a T cell-dependent antibody response progresses.
Affinity maturation takes place in germinal centers of lymphoid tissues and is the result of somatic mutation of immunoglobulin genes, followed by selective survival of the B cells producing the highest affinity antibodies.
Avidity
The overall strength of interaction between two molecules, such as an antibody and antigen. Avidity depends on both the affinity and the valency of interactions.
Therefore, the avidity of a pentameric IgM antibody, with 10 antigen-binding sites, for a multivalent antigen is much greater than the affinity of a single antibody combining site specific for the same antigen.
Avidity can be used to describe the strength of cell-cell interactions, which are mediated by many binding interactions between cell surface molecules.
Cross-reactivity
Cross-reactivity measures the extent to which different antigens appear similar to the immune system. The molecular determinants of specificity and cross-reactivity define the nature of antigenic variation and the selective processes that shape the distribution of variants in populations.
Monoclonal antibody
An antibody that is specific for one antigen and is produced by a B cell hybridoma (a cell line derived by the fusion of a single normal B cell and an immortal B cell tumor line).
Monoclonal antibodies are widely used in research, clinical diagnosis, and therapy.
Hybridomas
Foo
Positive selection
The process by which developing T cells in the thymus (thymocytes) whose TCRs bind to self MHC molecules are rescued from programmed cell death, whereas thymocytes whose receptors do not recognize self MHC molecules die by default.
Positive selection ensures that mature T cells are self MHC restricted and that CD8+ T cells are specific for complexes of peptides with class I MHC molecules and CD4+ T cells for complexes of peptides with class II MHC molecules.
Negative selection
The process by which developing lymphocytes that express self-reactive antigen receptors are eliminated, thereby contributing to the maintenance of self tolerance.
Negative selection of developing T lymphocytes (thymocytes) is best understood and involves high-avidity binding of a thymocyte to self MHC molecules with bound peptides on thymic APCs, leading to apoptotic death of the thymocyte.